SCHEMBL4664283

SCHEMBL4664283

CC(C)(C#N)c1cccc(OC(N)=O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
CYP3A4 P08684 1/20 0.39
BRAF P15056 5/20 0.39
PRSS1 P07477 2/20 0.39
ACR P10323 2/20 0.39
PARP1 P09874 1/20 0.38
ATM Q13315 1/20 0.36
KIF11 P52732 1/20 0.36
OPRK1 P41145 1/20 0.36
KCNH2 Q12809 1/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
LMNA P02545 1/20 0.36
CYP2C9 P11712 1/20 0.35
ADAM17 P78536 1/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 1/20 0.35
RECQL P46063 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL80101 0.82 MEN1 (0.66) KMT2AMEN1CYP3A4PRSS1ACR
SCHEMBL1007659 0.77 ACHE (0.44) CYP3A4BRAFPRSS1PARP1KIF11
SCHEMBL16380694 0.76 PARP1 (0.49) BRAFPARP1KIF11OPRK1KCNH2
SCHEMBL29448779 0.76 PARP1 (0.49) BRAFPARP1KIF11OPRK1KCNH2
SCHEMBL27823092 0.76 MEN1 (0.66) KMT2AMEN1PRSS1ACRATM
SCHEMBL29920925 0.76 MEN1 (0.66) KMT2AMEN1PRSS1ACRATM
SCHEMBL4513039 0.74 JAK2 (0.36) CYP3A4BRAFATMLMNACYP2C9
SCHEMBL1592771 0.74 JAK2 (0.44) BRAFATMESR1ESR2CYP2C9
SCHEMBL28826217 0.74 L3MBTL1 (0.49) KMT2ACYP3A4KIF11CYP2C9MAPT
SCHEMBL2008254 0.73 TP53 (0.47) KMT2AMEN1CYP3A4LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007737-A2 CHEMICAL COMPOUNDS AstraZeneca AB (SE) 2008-12-31 EP disclosed
WO-2007113558-A2 QUINAZOLINONE DERIVATIVES HAVING B-RAF INHIBITORY ACTIVITY ASTRAZENECA AB (SE) 2007-10-11 WO disclosed